Prospective evaluation of percent free-PSA and complexed-PSA for early detection of prostate cancer

被引：0
|
作者：
AW Partin
MK Brawer
ENP Subong
CA Kelley
JL Cox
DJ Bruzek
J Pannek
GE Meyer
DW Chan
机构：
[1] The Brady Urological Institute,Department of Urology
[2] The Johns Hopkins Hospital,Department of Pathology
[3] The Brady Urological Institute,undefined
[4] The Johns Hopkins Hospital,undefined
[5] The University of Washington and Seattle Veterans Affairs Administration Medical Center,undefined
来源：
Prostate Cancer and Prostatic Diseases | 1998年 / 1卷
关键词：
prostate cancer; detection; percent ; -PSA; complexed-PSA; prospective;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Aims of the study: Retrospective studies investigating the use of percent free-PSA for early detection of prostate cancer were limited for various reasons: by their use of long-term stored sera, poor mix of non-cancer to cancer cases and the use of only men with PSA values between 4.0 and 10.0 ng/mL. This prospective study investigates the clinical utility of percent free-PSA and complexed-PSA for early detection of prostate cancer in 219 consecutive men presenting for prostate biopsy.
引用
收藏
页码：197 / 203
页数：6
相关论文
共 50 条
  • [31] Complexed PSA and Total PSA in patients with Benign Prostate Hyperplasia and Prostate Cancer
    Tamimi, W.
    Dafterdar, R.
    Mansi, M.
    Alsaad, K.
    CLINICAL CHEMISTRY, 2009, 55 (06) : A111 - A111
  • [32] Short-term stability of the molecular forms of PSA and effect on percent free PSA (%fPSA) and percent complexed PSA (%cPSA).
    Sokoll, LJ
    Bruzek, DJ
    Dua, R
    Dunn, W
    Mohr, P
    Wallerson, C
    Chan, DW
    CLINICAL CHEMISTRY, 2001, 47 (06) : A139 - A140
  • [33] Complexed PSA for early detection of prostate cancer in men with serum PSA levels of 2-4 ng/mL
    Bartsch, G
    Cheli, CD
    Horninger, W
    Babaian, RJ
    Fritsche, HA
    Lepor, H
    Taneja, S
    Childs, S
    Stamey, TA
    Sokoll, L
    Chan, D
    Brawer, MK
    Partin, AW
    JOURNAL OF UROLOGY, 2002, 167 (04): : 208 - 208
  • [34] Complexed PSA enhances specificity in the detection of prostate cancer.
    Cheli, CD
    Miller, MC
    Veltri, R
    CLINICAL CHEMISTRY, 2001, 47 (06) : A128 - A128
  • [35] Ratio of free-PSA/total-PSA: An indicator for differentiation between patients with prostate cancer and benign prostatic hyperplasia
    Lein, M
    Stephan, C
    Jung, K
    Koenig, F
    Schnorr, D
    Loening, SA
    AKTUELLE UROLOGIE, 1997, 28 (06) : 323 - 328
  • [36] Systematic 12-core biopsy degrades performance of percent free PSA and PSA density for prostate cancer detection
    Singh, H
    Canto, EI
    Shariat, SF
    Kadmon, D
    Miles, BJ
    Slawin, KM
    JOURNAL OF UROLOGY, 2003, 169 (04): : 428 - 429
  • [37] International multi-center comparison of complexed PSA (cPSA) with total PSA and percent free PSA.
    Cheli, CD
    Brawer, MK
    Filella, X
    Mitchell, I
    Babaian, RJ
    Miller, C
    Partin, A
    Trock, BJ
    CLINICAL CHEMISTRY, 2004, 50 (06) : A79 - A79
  • [38] VALUE OF LONGITUDINAL PERCENT FREE PSA IN PROSTATE CANCER DIAGNOSIS
    Benecchi, Luigi
    Potenzoni, Michele
    Pastizzaro, Carmelo Destro
    Uliano, Nicoletta
    Pieri, Anna Maria
    JOURNAL OF UROLOGY, 2011, 185 (04): : E809 - E809
  • [39] The role of free PSA in the detection of prostate cancer
    Southwick, PC
    LABORATORY MEDICINE, 2001, 32 (05) : 259 - 263
  • [40] Comparison of percent free-PSA and Prostasure™ index in separating prostate cancer from bph and normal in men with a psa level between 2.5-4.0 ng/ml
    Zhang, Z
    Stamey, TA
    Oesterling, JE
    Zhang, H
    Madyastha, KR
    Barnhill, SD
    JOURNAL OF UROLOGY, 1998, 159 (05): : 109 - 109
12345